Sector Pulse — March 23, 2026

Technology

Theme

AI infrastructure remains the dominant narrative, but leadership is concentrating in companies with real revenue capture, supply-chain leverage, and mission-critical positioning rather than pure AI labeling. At the same time, valuation, governance, and financing discipline are becoming more important, with investors rewarding execution and punishing narrative excess.

Movers

NVDA(Nvidia) remained the center of the AI buildout, reinforced by its role across GPU infrastructure, partnerships, and the broader ecosystem. What matters is that Nvidia is no longer just a chip winner—it is the core dependency of the AI stack, which keeps capital flowing into adjacent suppliers and enablers.
TSM(Taiwan Semiconductor) continued to look like the systemic bottleneck and backbone of AI hardware, with advanced-node and packaging demand still overwhelming supply. This matters because AI growth is increasingly constrained by foundry capacity, not end demand.
AVGO(Broadcom) strengthened its claim as a foundational AI infrastructure winner, with AI revenue growth and networking leadership reinforcing the view that AI compute bottlenecks are moving beyond GPUs into connectivity and custom silicon.
DELL(Dell Technologies) gained credibility as a scaled AI server and enterprise infrastructure beneficiary, especially after bullish AI-server revenue expectations. That matters because the market is broadening beyond semis into integrated system vendors with real enterprise distribution.
CRWV(CoreWeave) highlighted the other side of the AI boom: explosive demand and backlog paired with extreme capex intensity. It matters because GPU cloud demand is real, but financing and execution risk are now central to the equity story.
SMCI(Super Micro Computer) became the day’s clearest governance casualty after allegations tied to illegal AI server exports to China. This matters far beyond one stock because AI hardware supply chains are now a geopolitical compliance issue, not just a growth theme.
SNPS(Synopsys) and CDNS(Cadence Design Systems) both underscored that EDA is becoming a leveraged way to play AI and next-gen chip complexity, with Synopsys attracting activist pressure and Cadence pushing deeper into photonics. This matters because design complexity is rising as fast as compute demand.
ANET(Arista Networks), CIEN(Ciena), COHR(Coherent), LITE(Lumentum), CRDO(Credo Technology), and ALAB(Astera Labs) all reinforced the same broader story: the optical/connectivity layer is becoming as strategically important as compute. Investors are increasingly recognizing that AI capex is spreading through the entire datacenter fabric.
ORCL(Oracle) and AMZN(Amazon) highlighted the hyperscaler split: both are capturing AI infrastructure demand, but the market is becoming more sensitive to debt, capex discipline, and project execution. Oracle’s legal and funding concerns matter because they show AI enthusiasm is no longer enough to shield weak execution.
MSFT(Microsoft) and GOOGL(Alphabet) remained core AI infrastructure and software platforms, but the introduction of credit-default-swap attention on hyperscalers suggests markets are beginning to price balance-sheet risk alongside AI upside.
CRM(Salesforce), NOW(ServiceNow), HUBS(HubSpot), and DDOG(Datadog) showed that AI monetization in enterprise software is separating leaders from hopefuls. The market increasingly wants actual adoption and paid expansion, not just product announcements.
PANW(Palo Alto Networks), CRWD(CrowdStrike), ZS(Zscaler), CSCO(Cisco), FTNT(Fortinet), and RBRK(Rubrik) all pointed to AI-era cybersecurity becoming a major spending category of its own. The broader takeaway is that AI adoption is creating a second-order security spend cycle.
AAPL(Apple), ADBE(Adobe), and ADSK(Autodesk) show a different AI lane: installed-base monetization. Apple has product-cycle optionality, Adobe is fighting monetization skepticism despite strong usage, and Autodesk is being rewarded for pairing recurring revenue with agentic-AI expansion.

Actionable Ideas (Positive)

AVGO(Broadcom) — AI revenue growth, networking leadership, and credible long-term AI revenue targets support a high-conviction infrastructure winner thesis. The actionable angle is that Broadcom sits in one of the highest-value choke points of AI scaling: custom compute interconnect.
TSM(Taiwan Semiconductor) — AI demand remains structurally supply-constrained, and TSMC continues to own the most important manufacturing bottleneck. The actionable angle is scarcity value plus pricing power at the center of AI deployment.
DELL(Dell Technologies) — rising confidence in AI server revenue and renewed institutional validation support further upside. The actionable angle is AI systems demand broadening beyond chipmakers into enterprise hardware assemblers with scale.
CDNS(Cadence Design Systems) — the company’s move into photonic design and AI-centric multiphysics workflows supports a bullish re-rating case. The actionable angle is higher chip complexity should drive rising software intensity in design.
CRDO(Credo Technology) — accelerating adoption in AI interconnect, hyperscaler traction, and roadmap execution around 800G/1.6T create a compelling growth setup. The actionable angle is connectivity remains one of the cleanest second-derivative AI trades.
GLW(Corning) — AI datacenter optical demand is becoming a meaningful growth engine, and the stock still trades below prior highs. The actionable angle is underappreciated exposure to the physical buildout of AI infrastructure.
HPE(Hewlett Packard Enterprise) — its NVIDIA-backed AI Grid and stable enterprise reputation support a catch-up trade versus higher-beta AI infrastructure names. The actionable angle is lower-governance-risk AI infrastructure exposure.
SNPS(Synopsys) — Elliott’s stake adds a catalyst layer on top of structural AI tailwinds. The actionable angle is AI-driven EDA growth plus potential margin/capital allocation upside from activism.
HUBS(HubSpot) — the AI product bundling strategy and improving sentiment after the conference create a credible turnaround setup. The actionable angle is AI monetization through installed SMB relationships at a compressed sentiment base.

Actionable Ideas (Negative)

SMCI(Super Micro Computer) — alleged export-control violations tied to senior leadership create a serious governance and regulatory overhang. The actionable angle is that even strong AI demand cannot offset a trust and compliance crisis.
ORCL(Oracle) — capex strain, legal overhang, delayed AI infrastructure delivery, and funding concerns make this vulnerable if execution slips further. The actionable angle is AI upside is now competing with balance-sheet and credibility risk.
CRWV(CoreWeave) — backlog is enormous, but capex needs and debt dependence make the equity highly fragile if financing conditions tighten. The actionable angle is capital intensity may cap upside before demand does.
AI(C3.ai) — the stock’s move was explicitly sentiment-driven rather than fundamental. The actionable angle is it remains one of the cleaner shorts on AI narrative excess if risk appetite fades.
MDB(MongoDB) — AI ambition remains ahead of monetization, while valuation and slowing confidence leave the stock vulnerable. The actionable angle is execution needs to catch up quickly to premium expectations.
ADBE(Adobe) — strong business quality is being overshadowed by CEO transition risk, stock business losses, and monetization concerns. The actionable angle is good fundamentals may not stop multiple compression if leadership uncertainty persists.
NTNX(Nutanix) — a softer market view amid AI-era infrastructure competition suggests the stock could struggle to hold premium software positioning. The actionable angle is legacy infrastructure software is losing the market’s imagination premium.

Financials

Theme

The financial sector was shaped by a mix of regulatory relief, private-credit stress, and selective growth optimism. Banks and diversified financials benefited from a broad risk-on macro move, but the more durable story is that capital rule easing and strategic repositioning are creating winners, while private-credit liquidity and legal overhangs are exposing weak spots.

Movers

BAC(Bank of America), JPM(JPMorgan Chase), PNC(PNC Financial Services), TFC(Truist Financial), and WFC(Wells Fargo) all benefited from the market’s focus on the Fed’s proposed easing of capital requirements. The broader significance is that large banks may soon have more flexibility for lending, buybacks, and balance-sheet growth.
JPM(JPMorgan Chase) stood out for its broad strategic reach: leveraged finance, CDS innovation, mortgage optionality, and regulatory upside. It matters because JPM continues to consolidate its role as the systemically advantaged U.S. bank.
WFC(Wells Fargo) remains one of the clearest beneficiaries of asset cap removal plus higher-for-longer rates, making it a recovery story shifting into a normalized earnings story.
APO(Apollo Global Management) and MS(Morgan Stanley) highlighted a more fragile undercurrent: private-credit redemption pressure and liquidity management are becoming more visible market issues.
BX(Blackstone) benefited from the contrast with peers restricting redemptions, reinforcing the market view that liquidity optics matter in alternatives, even if fundamentals remain sound.
KKR(KKR) was pressured by the repricing of software/SaaS credit exposure, a reminder that AI disruption is now filtering into private asset valuation and credit underwriting.
COF(Capital One Financial) and PYPL(PayPal) both faced legal/reputational overhangs that matter because the market is increasingly intolerant of governance and disclosure slippage in consumer finance.
MA(Mastercard) and V(Visa) pushed the payments narrative toward AI commerce, digital infrastructure, and blockchain rails, showing that the next phase of payments competition is being fought on platform relevance, not card penetration.
NDAQ(Nasdaq) and CBOE(Cboe Global Markets) showed exchanges moving deeper into tokenization and more exotic trading products, reinforcing the trend that market structure itself is becoming a growth arena.
ZION(Zions Bancorporation) made a meaningful strategic move in multifamily and agency lending, suggesting regionals with the right niche can still find profitable expansion lanes.
CPAY(Corpay) stood out as one of the clearest examples of market misunderstanding creating opportunity, as stablecoin fears continue to obscure its real moat in spend optimization and compliance.
SOFI(SoFi Technologies) remains one of the sector’s highest-beta battlegrounds, where strong growth is being drowned out by accounting scrutiny and credibility risk.

Actionable Ideas (Positive)

WFC(Wells Fargo) — asset cap relief plus higher net interest income leverage creates a credible re-rating setup. The actionable angle is regulatory normalization can unlock earnings power the market has long discounted.
BAC(Bank of America) — capital rule relief, improving credit card trends, and solid dividend support make the setup constructive. The actionable angle is regulatory easing could enhance both loan growth and capital return.
CPAY(Corpay) — the market’s stablecoin anxiety is masking a strong cross-border and spend-management franchise. The actionable angle is misunderstood fintech infrastructure with a clear path to re-rating.
BX(Blackstone) — in a market newly sensitive to private-credit liquidity, Blackstone appears to be benefiting from relative strength and capital confidence. The actionable angle is quality leadership in alternatives can gain share when weaker peers wobble.
ZION(Zions Bancorporation) — the Basis acquisition gives the bank a meaningful entry into higher-value agency lending. The actionable angle is fee income and specialized CRE lending can improve its earnings mix.
JPM(JPMorgan Chase) — regulatory flexibility, durable credit quality, and unmatched strategic breadth keep the bullish case intact. The actionable angle is JPM remains the highest-quality way to own U.S. banking scale.

Actionable Ideas (Negative)

APO(Apollo Global Management) — redemption caps and private-credit stress are a warning that liquidity assumptions are being challenged. The actionable angle is headline resilience may crack if investor confidence in private credit worsens.
MS(Morgan Stanley) — capping redemptions in private credit is manageable, but it is still a clear negative signal. The actionable angle is wealth and advisory stability may not fully offset alternative asset perception risk.
COF(Capital One Financial) — legal risk tied to the Trump lawsuit remains an overhang. The actionable angle is litigation plus reputational damage could outweigh software optionality near term.
SOFI(SoFi Technologies) — growth remains strong, but the accounting challenge from short-sellers is too large to ignore. The actionable angle is until transparency improves, valuation support is unreliable.
MA(Mastercard) — Banco Master exposure highlights a real counterparty-risk blind spot in emerging-market partner models. The actionable angle is premium valuation leaves little room for ecosystem risk surprises.
KKR(KKR) — software credit exposure is becoming less attractive as AI changes private-market valuation assumptions. The actionable angle is private asset markdown risk may be underappreciated.

Healthcare

Theme

Healthcare was defined by a sharp split between innovation winners and execution/growth laggards. The strongest stories came from clinically validated platform expansion—especially in obesity, oncology, diagnostics, and medtech automation—while the weaker names were those where valuation, demand stagnation, or legal/operational stress overwhelmed the bull case.

Movers

LLY(Eli Lilly) and NVO(Novo Nordisk) remain the central pillars of the obesity drug story, but today’s developments showed that the market is broadening to pipeline depth, dosing convenience, and next-wave therapies rather than simply current blockbuster leadership.
ABBV(AbbVie) made a meaningful entrance into the obesity discussion with encouraging early-stage data for ABBV-295. This matters because large-cap pharma is still looking for ways to break the Lilly/Novo duopoly.
ABT(Abbott Laboratories) transformed its diagnostics profile via the Exact Sciences acquisition. This matters because cancer screening and precision diagnostics remain one of the most valuable strategic adjacencies in healthcare.
GH(Guardant Health) benefited from Quest integration of Shield, showing that commercial distribution can be as important as clinical innovation in diagnostics.
IONS(Ionis Pharmaceuticals) and INSM(Insmed) both delivered important clinical/regulatory progress, reinforcing that late-stage biotech still gets paid when data are clean and relevant.
VRTX(Vertex Pharmaceuticals) continues to show that biotech multiple expansion follows de-risked diversification, not just single-franchise success.
DHR(Danaher), DHR via Leica, and DHR’s AI-enabled pathology push highlighted the medtech/diagnostics automation theme. Similarly, DHR, GEHC(GE HealthCare), and MDT(Medtronic) all showed that AI and workflow integration are now central to medtech product cycles.
BMY(Bristol Myers Squibb), GSK(GSK), GILD(Gilead Sciences), and NVS(Novartis) all contributed to a broader message: large pharma is still willing to spend aggressively to reshape pipeline narratives, especially in oncology, immunology, and specialty disease.
PFE(Pfizer) and MRK(Merck) highlighted a more nuanced reality: both have meaningful strategic upside, but investors are demanding cleaner earnings trajectories and more confidence around pipeline monetization.
DGX(Quest Diagnostics), AVTR(Avantor), and LH(Labcorp) represented the weaker side of healthcare, where stagnant growth and margin pressure are increasingly punished even in defensive sectors.
ENPH(Enphase) should be ignored here—sector mismatch.
CNC(Centene) and UNH(UnitedHealth Group) reinforced a payer divergence: integrated scale and execution still command a premium, while turnaround stories without visibility remain suspect.

Actionable Ideas (Positive)

LLY(Eli Lilly) — NVIDIA collaboration, obesity franchise depth, and continued strategic expansion support a long-duration growth thesis. The actionable angle is Lilly remains the cleanest large-cap healthcare growth story tied to both therapeutics and AI-enabled R&D.
ABBV(AbbVie) — early obesity data create real optionality beyond the core immunology story. The actionable angle is the market may be underpricing obesity upside from a company with proven commercial muscle.
GH(Guardant Health) — Quest integration dramatically improves commercial reach for Shield. The actionable angle is distribution de-risks the path from innovation to adoption.
IONS(Ionis Pharmaceuticals) — FDA Priority Review for zilganersen is a major potential company-shaping catalyst. The actionable angle is possible first commercial neurology launch with orphan pricing power.
INSM(Insmed) — strong Phase 2/3 data for Arikayce create a credible re-rating setup. The actionable angle is late-stage data validation in rare disease can drive sustained upside.
VRTX(Vertex Pharmaceuticals) — successful non-CF pipeline progress supports further premium multiple durability. The actionable angle is diversification is now becoming visible, not hypothetical.
MDT(Medtronic) — OmniaSecure approval gives Medtronic a first-mover advantage in left bundle branch pacing. The actionable angle is clinical differentiation can drive share gains in a high-value device category.
DHR(Danaher) — AI-enabled pathology and workflow automation reinforce the recurring-revenue medtech platform. The actionable angle is digital pathology adoption remains a durable secular growth vector.

Actionable Ideas (Negative)

AVTR(Avantor) — flat growth and weak demand outlook make the valuation trap argument compelling. The actionable angle is life sciences exposure alone is not enough without visible volume recovery.
LH(Labcorp) — declining margins and lack of organic growth suggest the market may still be too forgiving. The actionable angle is mature diagnostics scale is becoming a disadvantage without productivity recovery.
DGX(Quest Diagnostics) — while Shield is strategically interesting, reimbursement and execution risk remain high against a weak organic backdrop. The actionable angle is investors may be overestimating how quickly oncology screening can offset slow legacy growth.
CNC(Centene) — weak profitability and reliance on government programs leave little room for error. The actionable angle is managed-care turnarounds without visibility tend to stay cheap.
MRK(Merck) — projected earnings collapse creates a risky setup despite strategic pipeline strengths. The actionable angle is valuation and quality can still compress when earnings credibility weakens.

Industrials

Theme

Industrials saw a clear bifurcation between structural infrastructure winners and names facing valuation or execution stress. The strongest stories were tied to AI-related power demand, defense modernization, electrification, and automation, while laggards were those where premium multiples are running ahead of fundamentals or litigation/governance clouds remain unresolved.

Movers

VRT(Vertiv), GNRC(Generac), EME(EMCOR), PWR(Quanta Services), and FAST(Fastenal) all pointed to the same bigger narrative: AI and electrification are driving a fresh infrastructure capex cycle.
GEV(GE Vernova) was one of the clearest industrial winners, benefiting from AI-linked power demand, turbine order growth, and a favorable long-term utility/energy setup. This matters because power generation is becoming a second-order AI beneficiary.
HON(Honeywell) and JCI(Johnson Controls) showed the value of building automation, efficiency, and energy resilience as industrial demand themes.
ETN was not in the feed, omitted.
CARR absent.
BA(Boeing) remains the highest-profile troubled industrial, with weak balance sheet quality and execution concerns offsetting defense backlog strength.
CAT(Caterpillar) highlighted the conflict between cyclical momentum and tariff risk, while CTAS(Cintas) and URI(United Rentals) offered more defensive/quality expressions of industrial demand.
GD(General Dynamics), RTX(RTX), LMT(Lockheed Martin), NOC(Northrop Grumman), KTOS(Kratos Defense), AVAV(AeroVironment), and ATI(ATI Inc.) all reinforced that defense spending remains a secular support, but supply chain and geopolitical shifts are changing where the best leverage lies.
MP(MP Materials) and GD’s related rare-earth theme are important industrial-adjacent developments because defense and industrial sovereignty are converging around critical materials and domestic processing.
ECL(Ecolab) stood out as an industrial company making a credible AI-adjacent pivot through datacenter cooling, which broadens the industrial AI beneficiary list beyond pure electrical equipment.

Actionable Ideas (Positive)

VRT(Vertiv) — order growth, backlog, and S&P 500 inclusion reinforce a best-in-class AI infrastructure utility-equipment story. The actionable angle is Vertiv remains one of the cleanest picks-and-shovels beneficiaries of datacenter buildout.
GEV(GE Vernova) — turbine demand and AI power scarcity are creating a durable earnings setup. The actionable angle is power generation is becoming essential infrastructure for the AI era.
PWR(Quanta Services) — backlog and EPS growth tied to grid and AI-related power buildout make the setup attractive. The actionable angle is electrification capex remains early, not late.
EME(EMCOR) — hyperscale datacenter and electrical construction exposure are driving a major backlog and earnings expansion story. The actionable angle is EMCOR has direct operating leverage to AI physical infrastructure buildout.
ECL(Ecolab) — the CoolIT acquisition creates a real AI datacenter cooling angle. The actionable angle is the market may still underappreciate Ecolab’s shift toward recurring high-value thermal infrastructure.
GD(General Dynamics) — strong backlog, supply-chain de-risking, and strategic submarine/manufacturing positioning support a quality defense-industrial thesis. The actionable angle is high-quality balance sheet plus defense modernization.
KTOS(Kratos Defense) — the SKY Perfect JSAT partnership gives Kratos meaningful leverage to 5G NTN and defense communications. The actionable angle is higher-growth defense-tech optionality at the edge of satellite and telecom convergence.
MP(MP Materials) — direct DoD support and guaranteed rare-earth economics make the strategic value proposition unusually strong. The actionable angle is state-backed domestic critical materials capacity can command a premium multiple.

Actionable Ideas (Negative)

BA(Boeing) — leverage, cash burn, and ongoing execution fragility still overwhelm the defense upside. The actionable angle is Boeing remains a balance-sheet and trust repair story, not a clean cyclical recovery.
CAT(Caterpillar) — tariff exposure is large enough to threaten margin durability despite operational momentum. The actionable angle is macro optimism may be underestimating policy risk.
BWXT(BWX Technologies) — strong fundamentals are now matched by a valuation that assumes near-perfect execution. The actionable angle is premium nuclear enthusiasm leaves little room for delays or disappointments.
HWM(Howmet Aerospace) — premium valuation and sensitivity to 2026–2027 ramp assumptions make the stock vulnerable. The actionable angle is great business, crowded trade.
CLH(Clean Harbors) — low growth against a high multiple creates an unfavorable setup. The actionable angle is valuation appears disconnected from underlying growth reality.

Energy

Theme

Energy was dominated by geopolitical repricing and the resulting divergence between upstream, LNG, and oil-sensitive end markets. The key message is that supply security is now central to energy investing, with LNG and gas infrastructure gaining strategic importance, while geopolitical de-escalation immediately pressures crude-linked names and boosts travel-linked consumers.

Movers

CVX(Chevron), XOM(Exxon Mobil), FANG(Diamondback Energy), APA(APA Corp.), and CTRA(Coterra Energy) all reflected the push-pull of geopolitical energy pricing. The broader story is that Middle East instability is being repriced unevenly across the oil and gas complex.
LNG(Cheniere Energy), VG(Venture Global), GLNG(Golar LNG), EXE(Expand Energy), and CQP(Cheniere Energy Partners) highlighted the biggest structural energy theme of the day: global LNG security and U.S. export advantage.
CVX(Chevron) and SHEL(Shell) were especially important because they showed that global majors are simultaneously beneficiaries of higher prices and victims of physical geopolitical disruption.
SLB(Schlumberger) and BKR(Baker Hughes) indicate where service/infrastructure names can benefit if outages and underinvestment create a new capex cycle.
DVN(Devon Energy) and ET(Energy Transfer) reflected how investors are favoring free-cash-flow and contracted infrastructure exposure inside energy.
BE(Bloom Energy) and OKLO(Oklo) added a parallel energy narrative: AI power demand is opening new lanes for nontraditional energy infrastructure names, though execution risk remains high.

Actionable Ideas (Positive)

LNG(Cheniere Energy) — Qatar disruption and global LNG tightness reinforce the strategic value of U.S. export capacity. The actionable angle is LNG is shifting from cyclical commodity story to geopolitical infrastructure scarcity asset.
VG(Venture Global) — contract wins, funding, and modular buildout create unusually strong leverage to the LNG repricing cycle. The actionable angle is faster-to-market LNG optionality in a structurally undersupplied global market.
GLNG(Golar LNG) — direct sensitivity to LNG supply dislocation and improving operational profile support the move. The actionable angle is scarcity plus floating infrastructure optionality.
ET(Energy Transfer) — long-term data-center-linked gas demand and high contracted cash flow support a durable income/growth case. The actionable angle is one of the better ways to own AI power demand through midstream.
DVN(Devon Energy) — ETF inflows into high-free-cash-flow strategies add technical support to a fundamentally cash-rich name. The actionable angle is quality E&Ps can outperform in a selective energy tape.
SLB(Schlumberger) — Mideast disruption could create a multi-year repair/reinvestment cycle. The actionable angle